Advances in understanding the molecular mechanisms mediating neuronal plasticity have provided important clues to the pathophysiology of drug abuse and addiction. Although substantial progress has been made in elucidating several key aspects of this process, e.g. the role of NMDA and AMPA receptors in mediating the induction and expression of activity-induced plasticity, respectively, critical features of this process are only partially understood. For example, it is now clear that enduring forms of synaptic plasticity require local translation of mRNAs that have been pre-positioned in the vicinity of synapses. However, we are only beginning to understand the mechanisms and molecules mediating mRNA trafficking and translation. In addition, recent studies have focused attention on the prevalence and importance of morphological changes associated with synaptic plasticity. However, how these changes occur and their relevance to functional plasticity are poorly defined. Accordingly, there is intense interest in understanding the molecular machinery that mediates and regulates these processes. To gain insights into these key features of synaptic plasticity, we plan to focus on two projects. In one, we will investigate the function and regulation of Tech, a RhoA GEF enriched in brain that has been implicated in regulating dendritic morphology. In the other, we will examine the role of the Translin/Trax RNA binding complex in mediating RNA trafficking in dendrites.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA000266-38
Application #
7903975
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
38
Fiscal Year
2009
Total Cost
$466,621
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Hinkle, Jared T; Perepezko, Kate; Bakker, Catherine C et al. (2018) Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis. Int J Geriatr Psychiatry 33:e131-e139
Hinkle, Jared T; Perepezko, Kate; Mills, Kelly A et al. (2018) Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease. Parkinsonism Relat Disord 55:8-14
Piard, Juliette; Umanah, George K Essien; Harms, Frederike L et al. (2018) A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy. Brain :
Hinkle, Jared T; Perepezko, Kate; Rosenthal, Liana S et al. (2018) Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias. Parkinsonism Relat Disord 47:50-56
Berger, Nathan A; Besson, Valerie C; Boulares, A Hamid et al. (2018) Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases. Br J Pharmacol 175:192-222
Chern, Yijuang; Chien, Ting; Fu, Xiuping et al. (2018) Trax: A versatile signaling protein plays key roles in synaptic plasticity and DNA repair. Neurobiol Learn Mem :
Paul, Bindu D; Snyder, Solomon H (2018) Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem Pharmacol 149:101-109
Vasavda, Chirag; Zaccor, Nicholas W; Scherer, Paul C et al. (2017) Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding. J Vis Exp :
Park, Alan Jung; Havekes, Robbert; Fu, Xiuping et al. (2017) Learning induces the translin/trax RNase complex to express activin receptors for persistent memory. Elife 6:
Fu, Chenglai; Xu, Jing; Cheng, Weiwei et al. (2017) Neuronal migration is mediated by inositol hexakisphosphate kinase 1 via ?-actinin and focal adhesion kinase. Proc Natl Acad Sci U S A 114:2036-2041

Showing the most recent 10 out of 108 publications